Lauren Merendino - Chief Commercial Officer at Day One Biopharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Issuer Symbol
DAWN on Nasdaq
All Insider Reports
All Insider Reports

Lauren Merendino - trading volume in the past year for Day One Biopharmaceuticals, Inc.

Holdings reported by Lauren Merendino for Day One Biopharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 50,809 $452,946 $8.91 17 Nov 2025 Direct
Stock Option (right to buy Common Stock) 110,000 30 Jan 2026 Direct Common Stock
Restricted Stock Units 74,000 30 Jan 2026 Direct Common Stock
Restricted Stock Unit (RSU) 44,252 15 Nov 2025 Direct Common Stock

Transactions reported by Lauren Merendino for Day One Biopharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.